News/Events

Juniper Pharma Services to Participate in Inaugural West Coast Advancing Drug Development Forum

6 days ago

Nottingham, UK – Juniper Pharma Services (JPS), a Contract Development and Manufacturing organisation (CDMO) specialising in the development of challenging small molecules, will be attending the 2nd ‘Advancing Drug Development Forum (ADDF) – Making the Impossible, Possible.’ on June 14th at the San Francisco Wine School, California. JPS will be joining key opinion leaders at

Juniper Pharma Services’ co-founder awarded CBE in the Queen’s New Year’s Honours List

6 months ago

Juniper Pharmaceuticals (Nasdaq:JNP), a diversified healthcare company focused on women’s health, today announced that Juniper Pharma Services co-founder Martyn Davies, PhD, has been appointed as a Commander of the Order of the British Empire (CBE) in Her Majesty’s 2018 New Year’s Honours List. The honours system recognises people who have made achievements in public life

Juniper Pharma Services and XenoGesis strengthen alliance in early drug development services

8 months ago

Nottingham, UK – Juniper Pharma Services and XenoGesis have extended their strategic alliance around their Enabling Technologies Rapid Screen through the addition of the gold standard PBPK modelling and simulation software, GastroPlusTM. This expanded partnership brings greater understanding of a compound’s potential exposure in both preclinical and clinical studies. Jointly they are already working in

Major Progress in Next Generation Medicines Initiative

10 months ago

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reached a key milestone in its work with CrystecPharma and the Advanced Manufacturing Supply Chain Initiative (AMSCI) to create a new platform to accelerate drug development. The contract development and manufacturing organisation (CDMO) now has CrystecPharma’s supercritical fluid technology platform

Webinar – The Importance of Dose Prediction for Early Drug Development

12 months ago

Juniper Pharma Services will be presenting a webinar with Xenogesis: The Importance of Dose Prediction for Early Drug Development at 3.00pm (BST) on Thursday 6th July 2017. The webinar will examine how gaining a thorough understanding of the chemical and pharmacological attributes of a drug substance through preclinical studies is paramount for providing an effective dosage form

Juniper Pharma Services Brings PSD-1 Spray Dryer Online

12 months ago

Nottingham, UK – Juniper Pharma Services (“the company” or “Juniper”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has broadened its manufacturing capabilities bringing on-line its new spray dryer following the successful installation and validation of the advanced manufacturing equipment at its UK-based site. The contract development and manufacturing organisation (CDMO) has seen significant interest

Juniper Pharma Services expands granulation capabilities

2 years ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has added a roller compactor to its enabling technologies platform to satisfy increasing market demand for its pharmaceutical development services. The UK-based contract development and manufacturing organisation (CDMO) has purchased a Gerteis MINI-PACTOR® to expand its granulation capabilities and

Webinar – An Integrated Bio-Pharmaceutics Approach For Effective Drug Development

2 years ago

Juniper Pharma Services will be presenting a webinar with Xenogesis: An Integrated Bio-Pharmaceutics Approach for Effective Drug Development at 3.00pm – 4.00pm (BST) on Thursday 8th September 2016. The webinar will examine why new drug candidates fail during development for many reasons, and will be centred around: Undesirable absorption and/or metabolism of the compound in man

Tablet press investment at Juniper Pharma Services

2 years ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has bolstered its tablet manufacturing capabilities following the purchase and validation of an additional tablet press. The investment by the UK-based contract development and manufacturing organisation (CDMO) significantly extends its tablet production capacity and further strengthens the company’s ability

Juniper Pharma Services strenghtens capsule capability with Xcelodose

2 years ago

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its early stage capsule filling expertise with the expansion of its Xcelodose® powder micro-dosing system as part of its suite of GMP capabilities. The move by the contract development and manufacturing organisation (CDMO) follows demand from its clients to